Compare BBY & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBY | RGC |
|---|---|---|
| Founded | 1966 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9B | 11.5B |
| IPO Year | 1994 | 2020 |
| Metric | BBY | RGC |
|---|---|---|
| Price | $62.38 | $29.11 |
| Analyst Decision | Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $78.58 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 178.9K |
| Earning Date | 05-28-2026 | 10-31-2025 |
| Dividend Yield | ★ 6.16% | N/A |
| EPS Growth | ★ 17.76 | N/A |
| EPS | ★ 5.04 | N/A |
| Revenue | ★ $41,691,000,000.00 | N/A |
| Revenue This Year | $1.22 | N/A |
| Revenue Next Year | $1.39 | N/A |
| P/E Ratio | $12.34 | ★ N/A |
| Revenue Growth | ★ 0.39 | N/A |
| 52 Week Low | $59.16 | $9.39 |
| 52 Week High | $84.99 | $950.00 |
| Indicator | BBY | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 43.27 | 54.24 |
| Support Level | $61.69 | $22.43 |
| Resistance Level | $68.68 | $37.83 |
| Average True Range (ATR) | 2.19 | 3.55 |
| MACD | 0.12 | 0.36 |
| Stochastic Oscillator | 39.47 | 35.65 |
With over $41 billion in consolidated 2024 sales, Best Buy is the largest pure-play consumer electronics retailer in the US, boasting roughly 8% share of the North American market and around 33% share of offline sales in the region, per our calculations, CTA, and Euromonitor data. The firm generates the bulk of its sales in-store, with mobile phones and tablets, computers, and appliances representing its three largest categories. Recent investments in e-commerce fulfillment, accelerated by the covid pandemic, have seen the US e-commerce channel roughly double from prepandemic levels, with management estimating that it will represent a mid-30% proportion of sales moving forward.
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.